Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 19, 2014

View Archived Issues

U.S. researchers prepare new anti-B7-H5 antibodies

Biscayne Pharmaceuticals present data on novel GHRH antagonist

Ossianix extends research collaboration with Lundbeck for CNS therapeutics

Ascendis reports interim data from phase II pediatric study of TransCon Growth Hormone

Promising data presented on novel drug for the treatment of pyruvate kinase deficiency

Bone Therapeutics' phase I/IIa trial of Allob in delayed-union fractures recommended to continue

OncoSynergy forms agreement with CMC Biologics

MicroRNAs identified as potential markers of epilepsy

Antiangiogenic gene therapy evaluated in phase I/II glioblastoma study

Cardiac biomarkers have prognostic significance in coronary artery disease

Midafresa intravenous injection 0.1% for status epilepticus launched in Japan

Emergent BioSolutions acquires portfolio of broad-spectrum antibiotics

USAID awards funding to DNDi for onchocerciasis and elephantiasis

Tetraphase's eravacycline is noninferior to ertapenem in cIAI

Amunix confirms option exercise by Eli Lilly for XTEN product

Cara Therapeutics' CR-845 safe and well tolerated in patients undergoing hemodialysis

Cerulean initiates phase I/IIa trial of CRLX-301 docetaxel-bearing nanoparticles

Preclinical characterization of a novel dual orexin receptor antagonist

Bayer files BLA for BAY-81-8973 for treatment of hemophilia A

Janssen licenses recombinant hyaluronidase technology from Halozyme

Olaparib receives E.U. approval for BRCA-mutated ovarian cancer

Lilly divulges dopamine D1 receptor PAMs

Cellectis and bluebird bio report development of HIV treatment

Janssen Pharmaceutica prepares new mGlu2 receptor modulators

Abraxane approved for additional indication of unresectable pancreatic cancer in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...